Safety alertSource: FDA Drug Enforcement Reports

Class II recall: Apollo Care, LLC: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Sub

FDA has classified a recall of Apollo Care, LLC's Semaglutide 2.25mg (0.9 mg/mL), 2.5 mL sterile multi-dose vials (NDC 71170-811-02, for subcutaneous injection only) as a Class II recall. The recall notice cites the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material in the product.

Most relevant for: pediatric patients prescribed semaglutide injections who may have received affected vials from Apollo Care, LLC

Read the original at FDA Drug Enforcement Reports

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.

Specialties

More pediatrics updates

Get updates for your specialty